000			00918nam a22001457a 4500
999			_c521793 _d521793
008			230227b ||||| |||| 00| 0 eng d
100			_aNarayanan, Krithiga _936991
245			_aDrug price control in India - an ongoing debate
260			_aEconomic and Political Weekly
300			_a57(50), Dec, 10, 2022: p.17-20
520			_aPrice control of life-saving essential medicines is the need of the hour, but the National Pharmaceutical Pricing Authority has allowed a hike of 10% in nearly 800 drugs and devices listed under the National List of Essential Medicines from 1 April 2022 because of the rising input costs. Prices of scheduled drugs are allowed an increase each year acc¬ording to the wholesale price index. Input costs are rising primarily because India is heavily dependent on China for drug imports.- Reproduced
773			_aEconomic and Political Weekly
906			_aDRUGS
942			_cAR